Azathioprine and cyclosporine A have been shown to be effective for the posterior uveitis seen in BD, as have biologic agents targeted against the IL-1 family of cytokines (such as anakinra and canakinumab) which are elevated in patients with BD.17,90,91. The gene discussed is IL1B; the disease is Behcet disease.